Class summary at a glance.

Every drug in the Cannabinoid class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 2tracked in Part D
CY24 Part D spend: $10.2Mcombined across class
Total Rx claims: 61K30K unique beneficiaries
Generic mfrs (active): 1across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Dronabinol

Brand: MARINOL · 61K Part D claims (CY24) · 30K beneficiaries · First FDA approval: 2017-05-10

1 generic mfrs 984 plans require PA

Low NADAC—

→

Avg plan cost—

Part D spend $10.2M

Class share

100%

of class CY24 spend

View profile →

Nabilone

Brand: Cesamet · — Part D claims (CY24) · First FDA approval: 2020-03-09

Brand-only (no generics)